Furthermore, PEG-LPrA2 inhibition of leptin signaling in diet-induced-obesity (DIO) mice treated with a carcinogen, 7,12-dimethylbenz[α]anthracene, (DMBA) delayed the onset of mammary tumors and reduced tumor growth. This evidence concerns the gene LEP and neoplasm.